| Ashley Eibling, | |
|
3983 Jackpot Rd, Grove City, OH 43123-8637 | |
| (614) 539-5301 | |
| Not Available |
| Full Name | Ashley Eibling |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 10 Years |
| Location | 3983 Jackpot Rd, Grove City, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073992848 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 014778 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohrh, Llc | 5991942898 | 142 |
News Archive
Although secondhand smoke (SHS) exposure in the United States dropped by half between 1999 to 2000 and 2011 to 2012, one in four nonsmokers - 58 million people - are still exposed to SHS, according to a new Vital Signs report from the Centers for Disease Control and Prevention.
One of the largest studies undertaken has explored the risk of transmitting HIV infection by an HIV infected partner to his non-infected gay partner. Results reveal that HIV positive men who are on medication for HIV that makes their virus load undetectable in blood are not likely to transmit the infection to their non-infected partners.
Scientists from the MRC's Laboratory of Molecular Biology (LMB) and the Albert Einstein College of Medicine have discovered a way to stop an enzyme responsible for many cancers.
New research suggests that the gut microbiome may help prevent the development of cow's milk allergy. Scientists at the University of Chicago found that gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions, while gut microbes transplanted from infants allergic to milk did not.
CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.
› Verified 5 days ago
| Provider Name | Novacare Rehabilitation Of Ohio Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1952970824 PECOS PAC ID: 0345159315 Enrollment ID: O20130523000206 |
News Archive
Although secondhand smoke (SHS) exposure in the United States dropped by half between 1999 to 2000 and 2011 to 2012, one in four nonsmokers - 58 million people - are still exposed to SHS, according to a new Vital Signs report from the Centers for Disease Control and Prevention.
One of the largest studies undertaken has explored the risk of transmitting HIV infection by an HIV infected partner to his non-infected gay partner. Results reveal that HIV positive men who are on medication for HIV that makes their virus load undetectable in blood are not likely to transmit the infection to their non-infected partners.
Scientists from the MRC's Laboratory of Molecular Biology (LMB) and the Albert Einstein College of Medicine have discovered a way to stop an enzyme responsible for many cancers.
New research suggests that the gut microbiome may help prevent the development of cow's milk allergy. Scientists at the University of Chicago found that gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions, while gut microbes transplanted from infants allergic to milk did not.
CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.
› Verified 5 days ago
| Provider Name | Ohrh, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770060212 PECOS PAC ID: 5991942898 Enrollment ID: O20131127001003 |
News Archive
Although secondhand smoke (SHS) exposure in the United States dropped by half between 1999 to 2000 and 2011 to 2012, one in four nonsmokers - 58 million people - are still exposed to SHS, according to a new Vital Signs report from the Centers for Disease Control and Prevention.
One of the largest studies undertaken has explored the risk of transmitting HIV infection by an HIV infected partner to his non-infected gay partner. Results reveal that HIV positive men who are on medication for HIV that makes their virus load undetectable in blood are not likely to transmit the infection to their non-infected partners.
Scientists from the MRC's Laboratory of Molecular Biology (LMB) and the Albert Einstein College of Medicine have discovered a way to stop an enzyme responsible for many cancers.
New research suggests that the gut microbiome may help prevent the development of cow's milk allergy. Scientists at the University of Chicago found that gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions, while gut microbes transplanted from infants allergic to milk did not.
CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.
› Verified 5 days ago
| Provider Name | Professional Therapeutic Services, Inc. |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1023686979 PECOS PAC ID: 1355253337 Enrollment ID: O20151005000030 |
News Archive
Although secondhand smoke (SHS) exposure in the United States dropped by half between 1999 to 2000 and 2011 to 2012, one in four nonsmokers - 58 million people - are still exposed to SHS, according to a new Vital Signs report from the Centers for Disease Control and Prevention.
One of the largest studies undertaken has explored the risk of transmitting HIV infection by an HIV infected partner to his non-infected gay partner. Results reveal that HIV positive men who are on medication for HIV that makes their virus load undetectable in blood are not likely to transmit the infection to their non-infected partners.
Scientists from the MRC's Laboratory of Molecular Biology (LMB) and the Albert Einstein College of Medicine have discovered a way to stop an enzyme responsible for many cancers.
New research suggests that the gut microbiome may help prevent the development of cow's milk allergy. Scientists at the University of Chicago found that gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions, while gut microbes transplanted from infants allergic to milk did not.
CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.
› Verified 5 days ago
| Provider Name | Physiotherapy Associates Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1952348419 PECOS PAC ID: 3577470442 Enrollment ID: O20160330001796 |
News Archive
Although secondhand smoke (SHS) exposure in the United States dropped by half between 1999 to 2000 and 2011 to 2012, one in four nonsmokers - 58 million people - are still exposed to SHS, according to a new Vital Signs report from the Centers for Disease Control and Prevention.
One of the largest studies undertaken has explored the risk of transmitting HIV infection by an HIV infected partner to his non-infected gay partner. Results reveal that HIV positive men who are on medication for HIV that makes their virus load undetectable in blood are not likely to transmit the infection to their non-infected partners.
Scientists from the MRC's Laboratory of Molecular Biology (LMB) and the Albert Einstein College of Medicine have discovered a way to stop an enzyme responsible for many cancers.
New research suggests that the gut microbiome may help prevent the development of cow's milk allergy. Scientists at the University of Chicago found that gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions, while gut microbes transplanted from infants allergic to milk did not.
CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Eibling, 3983 Jackpot Rd, Grove City, OH 43123-8637 Ph: (614) 539-5301 | Ashley Eibling, 3983 Jackpot Rd, Grove City, OH 43123-8637 Ph: (614) 539-5301 |
News Archive
Although secondhand smoke (SHS) exposure in the United States dropped by half between 1999 to 2000 and 2011 to 2012, one in four nonsmokers - 58 million people - are still exposed to SHS, according to a new Vital Signs report from the Centers for Disease Control and Prevention.
One of the largest studies undertaken has explored the risk of transmitting HIV infection by an HIV infected partner to his non-infected gay partner. Results reveal that HIV positive men who are on medication for HIV that makes their virus load undetectable in blood are not likely to transmit the infection to their non-infected partners.
Scientists from the MRC's Laboratory of Molecular Biology (LMB) and the Albert Einstein College of Medicine have discovered a way to stop an enzyme responsible for many cancers.
New research suggests that the gut microbiome may help prevent the development of cow's milk allergy. Scientists at the University of Chicago found that gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions, while gut microbes transplanted from infants allergic to milk did not.
CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.
› Verified 5 days ago
Devon Smith Nyktas, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2600 Cameron St, Grove City, OH 43123 Phone: 614-589-8073 | |
Joy D. Atwood, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3983 Jackpot Rd, Grove City, OH 43123 Phone: 614-539-5301 Fax: 614-539-8658 | |
Jared William Bloom, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6024 Hoover Rd, Suite D, Grove City, OH 43123 Phone: 614-871-3832 Fax: 614-871-7225 | |
Tabitha L Bear, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 5500 N Meadows Dr, Grove City, OH 43123 Phone: 614-488-1816 | |
Jessica Marie Galasso, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5500 N Meadows Dr, Grove City, OH 43123 Phone: 614-488-1816 Fax: 614-488-0390 | |
William T Demis, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2185 Stringtown Rd, Grove City, OH 43123 Phone: 614-539-5301 Fax: 614-539-8658 |